MOVA Pharmaceutical Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

MOVA Pharmaceutical General Information

Description

Provider of pharmaceutical product manufacturing services to the pharmaceutical companies and emerging biotechnology companies. The company's services include raw material procurement, raw material testing, full scale testing, product release testing, stability testing, regulatory services and process improvement.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • P.O Box 8639
  • Caguas, PR 00726
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MOVA Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MOVA Pharmaceutical‘s full profile, request access.

Request a free trial

MOVA Pharmaceutical Patents

MOVA Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-602004030439-D1 Hopper with flow control / enhancer for controlling the heavy duty flow of granular material Active 17-Dec-2003 000000000
EP-1622820-B1 Hopper with flow controller/enhancer for controlling the gravitational flow of granular material Active 17-Dec-2003 000000000
EP-1622820-A2 Hopper with flow controller/enhancer for controlling the gravitational flow of granular material Active 17-Dec-2003 000000000 0
EP-1622820-A4 Hopper with flow controller/enhancer for controlling the gravitational flow of granular material Active 17-Dec-2003 000000000 0
US-20080259721-A1 Hopper with flow controller/enhancer for controlling the gravitational flow of granular material Inactive 17-Dec-2003 B65D88/64 00
To view MOVA Pharmaceutical’s complete patent history, request access »